KCT0000408招募中未知
Predictive and personalized medicine for rheumatoid arthritis through next generation genetic technology
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 16(Year) 至 100(Year)（—）
- 性别
- All
入选标准
- •Consecutive RA patients who visit Hanyang University Hospital for Rheumatic Diseases and give the informed consent
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
3 期
Comparing the effectiveness of our tailor-made management approach for rheumatoid arthritis with routine care from a clinical, patient, as well as economic point of viewRheumatoid arthritisISRCTN16170070Erasmus University Medical Center300
招募中
4 期
PeRsonalIzed MEdicine in Rheumatoid Arthritis (PRIMERA trial): a multicenter, single-blinded, randomized controlled trial comparing usual care with a tailor-made approachSymmetrical (small) joint inflammation with or without auto-antibodies1000381610013361Rheumatoid ArthritisNL-OMON49359Erasmus MC, Universitair Medisch Centrum Rotterdam300
尚未招募
2 期
Personalized Therapy in Rheumatoid Arthritis 2.0M05M06Seropositive rheumatoid arthritisOther rheumatoid arthritisDRKS00028144BKK Landesverband Bayern440
招募中
不适用
Microbiota Analysis to Predict Outcomes of Rheumatoid Arthritis Patients Treated With JAK-inhibitorRheumatoid ArthritisNCT04530305University Hospital, Montpellier60
已完成
不适用
BIOmarker-driven DEcision Study with Adalimumab (BIODESA)Rheumatoid arthritisISRCTN61158084niversity Hospital Regensburg (Universitätsklinikum Regensburg) (Germany)60